Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
ICD-10 M05.7 is a billable code used to indicate a diagnosis of rheumatoid arthritis with rheumatoid factor without organ or systems involvement.
Rheumatoid arthritis (RA) is a chronic inflammatory disorder primarily affecting the synovial joints, characterized by the presence of rheumatoid factor (RF) in the serum. Anatomically, RA typically involves the small joints of the hands and feet, but can also affect larger joints such as the knees and shoulders. The pathophysiology involves an autoimmune response leading to synovial inflammation, joint erosion, and systemic manifestations. Clinically, patients present with joint pain, stiffness, and swelling, particularly in the morning or after periods of inactivity. The absence of organ or systemic involvement differentiates this code from other forms of RA, allowing for focused treatment strategies aimed at managing joint symptoms and preventing functional decline.
Orthopedic documentation should include imaging studies (X-rays, MRIs) to assess joint damage and functional assessments to evaluate mobility and pain levels.
Common scenarios include joint injections for pain relief, arthroscopy for joint evaluation, and surgical interventions for severe joint damage.
Documentation must detail the specific joints involved and the degree of functional impairment to justify surgical interventions.
Rheumatologic documentation should include laboratory results for RF and anti-CCP antibodies, as well as assessments of disease activity using tools like the DAS28 score.
Management of RA flares, initiation of DMARD therapy, and monitoring for potential side effects of treatment.
Attention to systemic involvement is crucial, as it can change treatment protocols and coding.
Functional assessments should evaluate range of motion, strength, and endurance, along with rehabilitation goals.
Rehabilitation following joint surgery or therapy for pain management and mobility enhancement.
Documentation should address mobility limitations and the need for assistive devices.
Used for patients with RA experiencing joint effusion and pain.
Document the joint involved, indication for the procedure, and any prior treatments.
Orthopedic and rheumatologic considerations for joint health and management.
Documentation should include clinical findings of joint involvement, laboratory results showing positive rheumatoid factor, and a clear statement indicating the absence of systemic involvement. Additionally, any treatment plans and responses should be documented to support ongoing management.
